V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310011849 | 310008482 | 1.51 | null | Palliative (P) | 2016-06-11 | 2016-06-12 | METHOTREXATE | 2 | null | 310022562 | AZACITIDINE |
| 310011850 | 310005639 | 1.85 | 0 | Palliative (P) | 2018-08-31 | 2018-09-01 | Sunitinib | N | N | 310024263 | IRINOTECAN + MDG |
| 310011851 | 310005670 | 1.78 | 54.9 | Palliative (P) | 2019-07-10 | 2019-07-24 | RUXOLITINIB | null | null | 310025467 | OCTOPUS TRIAL |
| 310011852 | 310005674 | 1.8 | null | Palliative (P) | 2019-11-04 | 2019-11-12 | Vemurafenib | null | N | 310025486 | CVP R |
| 310011853 | 310005695 | 1.61 | 101.45 | Palliative (P) | 2017-04-11 | 2017-04-20 | RCEOP | N | N | 310003715 | CHLORAMBUCIL |
| 310011854 | 310005731 | 1.76 | 92.7 | Palliative (P) | 2019-11-26 | 2019-12-03 | Bortezomib + Cyclophos + Dex | null | null | 310024445 | CARBOPLATIN + PEMETREXED |
| 310011855 | 310002765 | 1.73 | null | Palliative (P) | 2020-07-05 | 2020-08-03 | CARBOPLATIN | 02 | null | 310004157 | CARBOPLATIN |
| 310011856 | 310002911 | 1.63 | 75.1 | Not known (9) | 2015-04-13 | 2015-04-18 | Carboplatin AUC 6 - 10 | N | null | 310004634 | CARBOPLATIN |
| 310011857 | 310007191 | null | 113 | Palliative (P) | 2016-04-13 | 2016-06-18 | CARBOPLATIN + PACLITAXEL | 02 | N | 310004655 | CARBOPLATIN + PACLITAXEL |
| 310011858 | 310002976 | 0 | 50.7 | Curative (C) | 2018-10-22 | 2018-10-29 | Carboplatin AUC 2 - 5 | 02 | N | 310004829 | CARBOPLATIN |
| 310011859 | 310002983 | 1.57 | 53 | Palliative (P) | 2016-05-31 | 2016-06-07 | Paclitaxel 7 day | 02 | N | 310004831 | PACLITAXEL |
| 310011860 | 310003239 | 1.66 | 58.4 | Palliative (P) | 2014-10-07 | 2014-10-23 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | 310005683 | PACLITAXEL |
| 310011861 | 310003263 | 1.59 | 57.2 | Palliative (P) | 2016-10-05 | 2016-10-12 | Carboplatin AUC 6 - 10 | N | N | 310005719 | CARBOPLATIN |
| 310011862 | 310003295 | 1.62 | null | Palliative (P) | 2019-11-01 | 2019-11-08 | Carboplatin AUC 2 - 5 | 2 | N | 310005782 | CARBOPLATIN |
| 310011863 | 310003302 | 1.65 | null | Palliative (P) | 2019-09-12 | 2019-10-05 | Bevacizumab 7.5mg/kg | 2 | N | 310005803 | BEVACIZUMAB |
| 310011864 | 310003444 | 1.7 | 78 | Palliative (P) | 2017-04-20 | 2017-08-05 | CHOP | 02 | N | 310006270 | CHOP |
| 310011865 | 310003491 | 1.53 | 77.9 | Disease modification (D) | 2019-10-21 | 2019-10-22 | Liposomal Doxorubicin (Caelyx) | N | N | 310006435 | LIPOSOMAL DOXORUBICIN |
| 310011866 | 310003520 | null | 102 | Palliative (P) | 2015-05-06 | 2015-05-06 | CHOP | 2 | N | 310006576 | CHOP |
| 310011867 | 310007426 | 1.69 | 86.4 | Palliative (P) | 2018-06-06 | 2018-06-06 | Trial Unspecified | Y | N | 310006623 | TRIAL |
| 310011868 | 310003665 | 1.57 | 52.1 | Palliative (P) | 2015-09-01 | 2015-09-01 | Liposomal Doxorubicin 40mg/m2 | N | N | 310007089 | LIPOSOMAL DOXORUBICIN |
| 310011869 | 310003680 | 1.8 | 79.9 | Neo-adjuvant (N) | 2017-09-24 | 2017-09-30 | Liposomal Doxorubicin 50mg/m2 | 02 | N | 310007131 | LIPOSOMAL DOXORUBICIN |
| 310011870 | 310003790 | 1.63 | 63.2 | Palliative (P) | 2015-02-02 | 2015-05-16 | PCE2BO (Etopophos®) | 2 | null | 310007569 | NOT MATCHED |
| 310011871 | 310003819 | null | 54.9 | Palliative (P) | 2019-08-08 | 2019-08-18 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 310007768 | CISPLATIN + GEMCITABINE |
| 310011872 | 310003866 | 1.73 | 94 | Curative (C) | 2015-02-24 | 2016-03-01 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 310008352 | CISPLATIN + GEMCITABINE |
| 310011873 | 310003977 | 1.79 | 63.4 | null | 2018-05-07 | 2018-06-04 | LEAM | 2 | N | 310010225 | LEAM |
| 310011874 | 310010607 | 1.7 | 18 | Curative (C) | 2018-03-22 | 2018-03-23 | Gemcitabine 1000mg/m2 D1 8 15 | 02 | null | 310010231 | GEMCITABINE |
| 310011875 | 310004051 | null | 72 | Neo-adjuvant (N) | 2018-02-03 | 2018-02-28 | CISPLATIN + GEMCITABINE | null | Y | 310012172 | CISPLATIN + GEMCITABINE |
| 310011876 | 310004094 | 1.87 | null | Palliative (P) | 2016-06-27 | 2017-03-10 | BEAM | N | null | 310013153 | BEAM |
| 310011878 | 310004193 | null | 82.5 | Palliative (P) | 2018-04-25 | 2018-04-27 | ALL Ph+ve Cons HR3 PAsp | N | N | 310014972 | NOT MATCHED |
| 310011879 | 310004199 | 1.59 | 89.7 | Palliative (P) | 2019-02-28 | 2019-03-21 | Carboplatin + Liposomal Doxorubicin | null | null | 310014991 | CARBOPLATIN + LIPOSOMAL DOX |
| 310011880 | 310004448 | 1.65 | 60.5 | Palliative (P) | 2018-08-03 | 2018-08-04 | GEMCITABINE | 2 | null | 310017474 | GEMCITABINE |
| 310011882 | 310004626 | 1.7 | 66.1 | Disease modification (D) | 2019-04-15 | 2019-04-23 | Bexarotene | N | N | 310018446 | ESHAP |
| 310011883 | 310007973 | null | 30 | Palliative (P) | 2014-12-02 | 2014-12-08 | BEVACIZUMAB + CARBO + PACLITAXEL | N | N | 310018467 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310011884 | 310004653 | 1.81 | 83.4 | Palliative (P) | 2017-09-03 | 2017-09-04 | CYCLOPHOSPHAMIDE + ETOPOSIDE + Procarbazine | Y | N | 310018504 | CYCLOPHOSPHAMIDE + ETOPOSIDE + PROCARBAZINE |
| 310011885 | 310004812 | 1.7 | 66 | Curative (C) | 2017-08-23 | 2017-08-24 | Bevacizumab+Carbo+Pacliaxel | Y | N | 310018968 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310011886 | 310004834 | 1.62 | 67 | Curative (C) | 2018-04-20 | 2018-09-09 | Ipilimumab | N | N | 310019038 | IPILIMUMAB |
| 310011887 | 310004912 | 1.66 | 61.1 | null | 2014-04-22 | 2014-04-28 | Etoposide oral | 02 | N | 310019371 | ETOPOSIDE |
| 310011888 | 310005001 | 1.61 | 55.1 | Palliative (P) | 2016-07-06 | 2016-07-06 | Carboplatin + Etoposide IV 3 day | N | N | 310019677 | BEXAROTENE |
| 310011889 | 310005013 | 1.71 | 69 | null | 2018-08-22 | 2018-08-22 | GEMCITABINE + VINORELBINE | 02 | N | 310019697 | METHOTREXATE |
| 310011890 | 310005253 | null | 88 | Disease modification (D) | 2018-09-09 | 2018-10-14 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | N | 310024543 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 310011891 | 310005266 | 1.81 | 99.4 | Palliative (P) | 2018-08-26 | 2019-05-27 | PEG INTERFERON | Y | Y | 310024633 | CYTARABINE HD + METHOTREXATE HD |
| 310011892 | 310005292 | 1.76 | 70.54 | Palliative (P) | 2016-05-30 | 2016-06-08 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | N | N | 310024934 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 310011893 | 310005297 | 1.64 | 82 | null | null | 2019-07-30 | EP | N | N | 310024973 | CAPECITABINE |
| 310011894 | 310005341 | 1.71 | 117.5 | Palliative (P) | 2017-10-19 | 2017-10-22 | Bendamustine + prednisolone | 02 | N | 310025341 | IVE-R |
| 310011895 | 310005366 | 1.64 | 0 | Neo-adjuvant (N) | 2017-02-04 | 2017-02-04 | Cytarabine HD + Methotrexate HD | 02 | N | 310025608 | TEMOZOLOMIDE |
| 310011896 | 310005386 | 1.68 | 85 | Curative (C) | 2017-01-05 | 2017-01-13 | CARBOPLATIN + CYCLOPHOSPHAMIDE + DOXORUBICIN + PACLITAXEL | 02 | N | 310025710 | CVD |
| 310011897 | 310008372 | 1.5 | 56.4 | Curative (C) | null | 2017-05-24 | Methotrexate High Dose (3g/m2) | N | N | 310025719 | SUNITINIB |
| 310011898 | 310005411 | 1.56 | 118 | Palliative (P) | 2018-08-14 | 2018-08-16 | Bendamustine + prednisolone | 2 | N | 310000469 | TEMOZOLOMIDE |
| 310011899 | 310008409 | 1.48 | 41.7 | Palliative (P) | 2017-06-22 | 2019-07-07 | ICON8 TRIAL | null | null | 310003601 | ICON TRIAL |
| 310011900 | 310005477 | 1.62 | 70.6 | Palliative (P) | 2019-09-09 | 2019-09-18 | Irinotecan | N | N | 310003761 | FLUDARABINE + MELPHALAN |